Erratum: Smoking status and survival in the national comprehensive cancer network nonsmall cell lung cancer cohort (Cancer (doi: 10.1002/cncr.27824));Smoking status and survival in the national comprehensive cancer network non-small cell lung cancer cohort

Cancer

Volumn 119, Issue 4, 2013, Pages 847-853

  Ferketich, Amy K ^a   Niland, Joyce C ^b   Mamet, Rizvan ^b   Zornosa, Carrie ^c   D'Amico, Thomas A ^d   Ettinger, David S ^e   Kalemkerian, Gregory P ^f   Pisters, Katherine M ^g   Reid, Mary E ^h   Otterson, Gregory A ⁱ  

^a OHIO STATE UNIVERSITY   (United States)

^b CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^c National Comprehensive Cancer Network   (United States)

^d DUKE CANCER INSTITUTE   (United States)

^e JOHNS HOPKINS UNIVERSITY   (United States)

^f UNIVERSITY OF MICHIGAN   (United States)

^g UNIVERSITY OF TEXAS   (United States)

^h ROSWELL PARK CANCER INSTITUTE   (United States)

ⁱ OHIO STATE UNIVERSITY   (United States)

Author keywords

non small cell lung cancer; prognosis; smoking; smoking cessation; survival analysis

Indexed keywords

ADULT; AGE; ARTICLE; CANCER PATIENT; CANCER STAGING; COHORT ANALYSIS; CONTROLLED STUDY; DATA BASE; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; MALE; NATIONAL COMPREHENSIVE CANCER NETWORK NON SMALL CELL LUNG CANCER DATABASE PROJECT; OVERALL SURVIVAL; PRIORITY JOURNAL; SMOKING; SURVIVAL RATE; SURVIVAL TIME;

EID: 84873406234     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.27796     Document Type: Erratum

References (22)

1. Parsons A, Daley A, Begh R, Aveyard P,. Influence of smoking cessation after diagnosis of early stage lung cancer on prognosis: systematic review of observational studies with meta-analysis [serial online]. BMJ. 2010; 340: b5569.
2. Baser S, Shannon VR, Eapen GA, et al. Smoking cessation after diagnosis of lung cancer is associated with a beneficial effect on performance status. Chest. 2006; 130: 1784-1790.
3. Kawahara M, Ushijima S, Kamimori T, et al. Second primary tumours in more than 2-year disease-free survivors of small-cell lung cancer in Japan: the role of smoking cessation. Br J Cancer. 1998; 78: 409-412.
4. Richardson GE, Tucker MA, Venzon DJ, et al. Smoking cessation after successful treatment of small-cell lung cancer is associated with fewer smoking-related second primary cancers. Ann Intern Med. 1993; 119: 383-390.
5. Tucker MA, Murray N, Shaw EG, et al. Second primary cancers related to smoking and treatment of small-cell lung cancer. Lung Cancer Working Cadre. J Natl Cancer Inst. 1997; 89: 1782-1788.
6. Rugg T, Saunders MI, Dische S,. Smoking and mucosal reactions to radiotherapy. Br J Radiol. 1990; 63: 554-556.
7. Mason DP, Subramanian S, Nowicki ER, et al. Impact of smoking cessation before resection of lung cancer: a Society of Thoracic Surgeons General Thoracic Surgery Database study. Ann Thorac Surg. 2009; 88: 362-370.
8. Erhunmwunsee L, Onaitis MW,. Smoking cessation and the success of lung cancer surgery. Curr Oncol Rep. 2009l; 11: 269-274.
9. Balduyck B, Nia PS, Cogen A, et al. The effect of smoking cessation on quality of life after lung cancer surgery. Eur J Cardiothorac Surg. 2011; 40: 1432-1437.
10. Meguid RA, Hooker CM, Harris J, et al. Long-term survival outcomes by smoking status in surgical and nonsurgical patients with non-small cell lung cancer: comparing never smokers and current smokers. Chest. 2010; 138: 500-509.
11. Toh CK, Wong EH, Lim WT, et al. The impact of smoking status on the behavior and survival outcome of patients with advanced non-small cell lung cancer: a retrospective analysis. Chest. 2004; 126: 1750-1756.
12. Herbst RS, Heymach JV, Lippman SM,. Molecular origins of cancer: lung cancer. N Engl J Med. 2008; 359: 1367-1380.
13. Subramanian J, Govindan R,. Molecular genetics of lung cancer in people who have never smoked. Lancet Oncol. 2008; 9: 676-682.
14. Sonobe M, Kobayashi M, Ishikawa M, et al. Impact of KRAS and EGFR gene mutations on recurrence and survival in patients with surgically resected lung adenocarcinomas. Ann Surg Oncol. 2012; 19 (suppl 3): 347-354.
15. Shaw AT, Yeap BY, Solomon BJ, et al. Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysis. Lancet Oncol. 2011; 12: 1004-1012.
16. Charlson ME, Pompei P, Ales KL, MacKenzie CR,. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis. 1987; 40: 373-383.
17. Zhou W, Heist RS, Liu G, et al. Smoking cessation before diagnosis and survival in early stage non-small cell lung cancer patients. Lung Cancer. 2006; 53: 375-380.
18. Nia PS, Weyler J, Colpaert C, Vermeulen P, Marck EV, Schil PV,. Prognostic value of smoking status in operated non-small cell lung cancer. Lung Cancer. 2005; 47: 351-359.
19. Ebbert JO, Williams BA, Sun Z, et al. Duration of smoking abstinence as a predictor for non-small-cell lung cancer survival in women. Lung Cancer. 2005; 47: 165-172.
20. Bryant A, Cerfolio RJ,. Differences in epidemiology, histology, and survival between cigarette smokers and never-smokers who develop non-small cell lung cancer. Chest. 2007; 132: 185-192.
21. Tammemagi CM, Neslund-Dudas C, Simoff M, Kvale P,. Smoking and lung cancer survival: the role of comorbidity and treatment. Chest. 2004; 125: 27-37.
22. Gillum RF, Kwagyan J, Obisesan TO,. Smoking, cognitive function and mortality in a US national cohort study. Int J Environ Res Public Health. 2011; 8: 3628-3636.